Anlotinib plus whole-brain radiotherapy for NSCLC brain metastases: a prospective, non-randomized, single-center cohort study

Abstract This study focuses on the vessel normalization window of anlotinib to preliminarily explore the optimal intervention timing for combining anlotinib with whole brain radiotherapy (WBRT) in treating brain metastases from non-small cell lung cancer (NSCLC). We aimed to explore the feasibility...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Shuai Li, Zongying Pan, Ruilin Chen, Shumei Xu, Yajie Wang, Guilin Zeng, Yamao Li, Lang He
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2026-05-01
Schriftenreihe:	Scientific Reports
Schlagworte:	Anlotinib Whole brain radiotherapy Non-small cell lung cancer Brain metastases Anti-angiogenesis
Online-Zugang:	https://doi.org/10.1038/s41598-026-52632-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!